Remove Atrial Fibrillation Remove Diabetes Remove Obesity
article thumbnail

Calpain inhibition takes center stage against atrial fibrillation in the diabetic heart

HeartRhythm

Diabetes mellitus (DM) is a public health problem that continues to grow worldwide. 1 Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting more than 6 million individuals in the United States.2 In the United States the Center for Disease Control and Prevention estimates that it affects 11.6%

article thumbnail

Challenges in the Cardiovascular Evaluation and Management of Patients With Obesity

American College of Cardiology

Obesity is a multifaceted disease that is directly and indirectly implicated in atherosclerotic cardiovascular disease (CVD), heart failure (HF), atrial fibrillation (AF), and multiple CVD risk factors, including dyslipidemia, hypertension, type 2 diabetes mellitus (DM), and sleep disorders.

Obesity 71
article thumbnail

Impact of Obesity on Atrial Fibrillation Pathogenesis and Treatment Options

Journal of the American Heart Association

ABSTRACTAtrial fibrillation (AF) is the most common cardiac arrhythmia. Obesity significantly increases AF risk, both directly and indirectly, through related conditions, like hypertension, diabetes, and heart failure. However, studies on how obesity affects pharmacologic or interventional AF treatments are limited.

Obesity 45
article thumbnail

Antithrombotic strategy in cancer patients comorbid with acute coronary syndrome and atrial fibrillation

Frontiers in Cardiovascular Medicine

Cancer, atrial fibrillation (AF) and coronary artery disease share some common factors and interact with each other, such as obesity, aging, diabetes, and inflammation, but the potential specific mechanism is still unclear. A growing number of studies have elucidated the association between cancer and CVD.

article thumbnail

Abstract 4141940: Outcomes in Middle Eastern Atrial Fibrillation Patients with Prior Ischemic Stroke/Systemic Embolism: Findings from the JoFib Study

Circulation

vs. 72.8%, p<0.001), had higher rates of diabetes (49.1% vs. 43.6%, p=0.007), and were less often obese (34.0% Circulation, Volume 150, Issue Suppl_1 , Page A4141940-A4141940, November 12, 2024. Compared to the no prior SSE group, those with prior SSE were less symptomatic (61.3% vs. 42.4%, p=0.03) and dyslipidemia (51.9%

article thumbnail

Higher Risk of Myocardial Infarction, Heart Failure, and Atrial Fibrillation Noted After Spinal Cord Injury

All About Cardiovascular System and Disorders

They have a greater prevalence of obesity, dyslipidemia, metabolic syndrome and diabetes mellitus. Higher risk of myocardial infarction, heart failure and atrial fibrillation was noted in spinal cord injury survivors compared to controls. Survivors with severe disability had the highest risk. Am J Phys Med Rehabil.

article thumbnail

PO-04-060 METFORMIN AND SGLT2I ARE ASSOCIATED WITH LOWER INCIDENT AF IN PATIENTS WITH CONTINUOUS RHYTHM MONITORING

HeartRhythm

Obesity, diabetes, and the metabolic syndrome are risk factors for atrial fibrillation (AF). AF is also associated with cardiomyocyte metabolic stress. We hypothesized that antidiabetic medications (ADMs) may affect AF incidence.